Muhammad Imran Amirzada has completed his Master of Science from Liverpool John Moores University, UK and Ph.D from Jiangnan University, P. R. China. Currently he is serving as Assistant Professor of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan. He has published research papers in reputed journals related to Recombinant Human Therapeutic Protein production. He has successfully win a project from Higher Education Comission (HEC) Pakistan for Recombinant Human Interleukin 24 with Doxyrubicin formulation. Muhammad Imran Amirzada has completed his Master of Science from Liverpool John Moores University, UK and Ph.D from Jiangnan University, P. R. China. Currently he is serving as Assistant Professor of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan. He has published research papers in reputed journals related to Recombinant Human Therapeutic Protein production. He has successfully win a project from Higher Education Comission (HEC) Pakistan for Recombinant Human Interleukin 24 with Doxyrubicin formulation.

Information Technology